[ACL] QoQ Quarter Result on 31-Mar-2021 [#Q3]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
30-Mar-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q3]
Profit Trend
QoQ- -97.11%
YoY- -92.02%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 538,001 269,001 328,798 164,399 317,904 158,952 244,017 69.15%
PBT 184,944 92,472 5,379 2,690 81,274 40,637 35,108 201.83%
Tax 54,656 27,328 2,063 1,032 24,201 12,101 -9,408 -
NP 130,214 65,107 3,300 1,650 57,073 28,537 44,455 104.31%
Tax Rate -29.55% -29.55% -38.35% -38.35% -29.78% -29.78% 26.80% -
Total Cost 407,787 203,894 325,498 162,749 260,831 130,416 199,562 60.81%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 24.20 24.20 1.00 1.00 17.95 17.95 18.22 20.76%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS 0.65 0.32 0.02 0.01 0.28 0.20 0.22 105.49%
EPS Diluted 0.65 0.32 0.02 0.01 0.28 0.20 0.22 105.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.